Time: October 23, 2012 from 1pm to 2pm
Location: Online Webinar from 1-2 pm Eastern Time Zone
Website or Map: http://www.readytalk.com/
Phone: 866.740.1260 -- Access code: 9449985
Event Type: webinar
Organized By: PPMD
Latest Activity: Oct 22, 2012
The webinar will be a discussion of the 48 Week dystrophin and 6-minute walk test (6MWT) data from the Phase IIb extension study in Duchenne as well as next steps for the eteplirsen program. Chris Garabedian, President and CEO of Sarepta Therapeutics will be presenting the data and answering submitted questions.
If you have questions you would like to submit to Sarepta, please email us at info@ParentProjectMD.org with “Sarepta Webinar” as the subject line. We will pass along all questions to Sarepta representatives prior to the 10/23 webinar.Please submit your questions no later than Friday, October 19 at noon eastern.
We appreciate Sarepta’s ongoing efforts to keep open lines of communications. We are always grateful when industry takes the time to communicate with the Duchenne community directly.